Health Care • Biotechnology: Laboratory Analytical Instruments
$384.40 ▼ -0.72
(-0.19%)
MKT CAP: $10.28B • VOL: 332.4K
52W L $237 52W H $396
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$323
MEDIAN
$431
MEAN
$438
HIGH
$523
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE BIO TAPE
BIO // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $465.12 | $442.06 | 2025-02-14 | $349.80 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $484.34 | $453.59 | 2025-02-06 | $361.34 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $438.22 | $422.84 | 2025-01-29 | $369.02 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $392.09 | — | 2025-01-17 | $376.71 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $338.27 | $365.18 | 2025-01-09 | $342.12 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $457.44 | $399.78 | 2024-12-18 | $334.43 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $372.87 | $388.24 | 2024-12-04 | $357.49 | -4.3% | 48% | C |